Please ensure Javascript is enabled for purposes of website accessibility

Karyopharm Therapeutics (KPTI)

Nasdaq Global Select

KPTI
Karyopharm Therapeutics  Stock Quote
$6.52 $0.26 4.2%
Price as of September 27, 2021, 4:00 p.m. ET View Interactive KPTI Charts

Karyopharm Therapeutics Inc. is a clinical-stage pharmaceutical company focused on the discovery and development of drugs directed against nuclear transport targets for the treatment of cancer and other major diseases.

Interactive Chart


Compare KPTI Stock to Peers


Symbol Last Price Market Cap % Δ 1 Yr % Δ 5 Yr
KPTI
Karyopharm Therapeutics
$6.52 $473M -58.0% -35.4%
CWBHF
$2.10 $366M -15.0%
OGI
$3.12 $914M 124.3% 82.6%
ANAB
$26.88 $750M 92.9%
BVXP
$3,975.00 $21B 0.6% 330.5%

News & Analysis: Karyopharm Therapeutics

All

Market Moves

Earnings